INC Research Achieves Most Consistent Service Quality Ratings in the CRO Industry According to the CRO Quality Benchmarking Report
(Thomson Reuters ONE) -
INC Research receives best Service Variability Index score, a measure of
consistency in meeting customer expectations, that far exceeds the industry
average
Raleigh, NC, Feb. 29, 2012 - INC Research, LLC, a therapeutically focused
clinical research organization (CRO) with a Trusted Process(®) for delivering
reliable results, today announced the Company has received the "most consistent
service quality ratings of all the companies profiled" in the 2012 CRO Quality
Benchmarking Report published by Industry Standard Research (ISR). For the 2012
study, ISR interviewed 125 individuals from 72 pharmaceutical and biotechnology
companies to provide insight into Phase II/III clinical development outsourcing
trends as well as assessments of CROs.
"INC Research prides itself on building strong relationships with its customers
and consistently delivering the highest quality clinical development services on
their behalf," said Jim Ogle, Chief Executive Officer. "This focus is the
essence of the Trusted Process(®), our proprietary, metrics-driven clinical
outsourcing methodology specifically designed to reduce variability while
maintaining a high standard of quality and remaining flexible to meet our
customers' complex and changing needs." He continued, "The results of this
survey further demonstrate that when you choose INC Research as your clinical
development partner you can expect your project to start quickly and
efficiently, your milestones to be met and your team to be comprised of the best
professionals in our industry."
The 2012 CRO Quality Benchmarking Report provides performance scorecards on 25
CROs, with CROs being scored across 21 critically important service capabilities
that affect provider selection and deliver quality. Key highlights of INC
Research's performance:
* INC Research received the best score on the Service Variability Index (SVI),
a measure of consistency in meeting customer expectations. The lower the
score, the less variability of the service provider from "ideal." INC
Research received a score of 14, substantially better than the industry
average of 25.
* INC Research scored better than the industry average for "Service Provider
Loyalty," "Overall Satisfaction with Service Providers," "Willingness to
Recommend Service Providers" and "Likelihood to Use Service Providers
Again."
* ISR recommends INC Research be shortlisted by companies who value
Operational Independence (turning studies over to experts who work
independently).
* INC Research received high marks for its global footprint and was
recommended to be shortlisted by companies planning global trials.
"In a year in which they completed a large acquisition, INC Research shows a
very solid performance profile," adds Kevin Olson, Chief Executive Officer,
Industry Standard Research. "The Company received the most consistent quality
ratings of all of the companies we profiled, and their customers are very
satisfied."
About ISR
Industry Standard Research is the premier, full-service market research provider
to the pharma and pharma services industries. With more than a decade of
experience in the industry, ISR delivers an unmatched level of domain expertise.
For more information, visit the ISR website at www.ISRreports.com or email
info(at)ISRreports.com. The company also may be found on Twitter (at)ISRreports.
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conductingglobal clinical development
programs of the highest integrity. Pharmaceutical and biotechnology companies
look to INC Research for a complete range of customized Phase I through Phase IV
programs in all therapeutic areas and innovative pediatric and women's health
trials. The Company's Trusted Process(®) methodology and therapeutic foresight
lead customers to more confident, better-informed drug and device development
decisions. INC Research is headquartered in Raleigh, NC. For more information,
please visit www.incresearch.com or follow us at (at)inc_research.
CONTACT: Lori Dorer, Media, (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
[HUG#1590268]
Unternehmensinformation / Kurzprofil:
Datum: 29.02.2012 - 19:50 Uhr
Sprache: Deutsch
News-ID 120390
Anzahl Zeichen: 5293
contact information:
Town:
Raleigh
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 155 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"INC Research Achieves Most Consistent Service Quality Ratings in the CRO Industry According to the CRO Quality Benchmarking Report"
steht unter der journalistisch-redaktionellen Verantwortung von
INC RESEARCH, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
